Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P9QW
|
|||
| Former ID |
DNCL003173
|
|||
| Drug Name |
Tipapkinogene sovacivec
|
|||
| Indication | Cervical Intraepithelial neoplasia [ICD-11: 2E66.1; ICD-10: N87.2] | Phase 2 | [1] | |
| Company |
Transgene
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human papillomavirus protein E6 (HPV E6) | Target Info | Modulator | [2], [3] |
| Human papillomavirus protein E7 (HPV E7) | Target Info | Modulator | [2], [3] | |
| Pathway Interaction Database | Regulation of Telomerase | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01022346) A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection. U.S. National Institutes of Health. | |||
| REF 2 | Immune therapy for human papillomaviruses-related cancers | |||
| REF 3 | Therapeutic peptides: new arsenal against drug resistant pathogens. Curr Pharm Des. 2014;20(5):771-92. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.